Pipeline

Dipharma SA works every day to provide high quality and highly pure products. Dipharma SA develops improved therapeutical formulations, aiming at simplifying patients’ lives and increasing patients compliance and adherence to pharmacological treatments. Dipharma SA is constantly and rapidly expanding its portfolio with improved generic products for the treatment of rare diseases, in particular directed to Inborn Errors of Metabolism (IEM). Dipharma SA efforts are always focused on making these treatments accessible and sustainable to patients all over the world.